Certara Inc at Jefferies Healthcare Conference Transcript
Welcome to the 2022 Jefferies Healthcare Conference. My name is Steven Couche. I'm filling in for Dave Windley, who is currently in quarantine trying to get a negative PCR test, so he can join us. I'm happy to be joined by the Certara team, William Feehery, CEO; and Andy Schemick, CFO. Thank you for being here.
Questions & Answers
So I guess we will jump right into it. Certara went public in December 2020. So a lot of questions we still get are around the industry in understanding biosimulation, which is roughly 2/3, maybe 70% of your business and then the additional 30-or-so percent is direct services with some market access.
If we think about the overall clinical development industry being 6%, 7%, 8%, but biosim being mid-teens. Maybe at the industry level, can you help us bridge that growth gap.
Yes. So
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |